Clinical Research Marketing Pharma Companies 
Vial
FEBRUARY 15, 2024
To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1. The demand for clinical trial outsourcing services is on the rise. over the forecast period (2022-2030).
H1 Blog
JULY 30, 2024
The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PerkinElmer
FEBRUARY 18, 2021
Dr. Eckelt conducted 23 hour-long, 1:1 interviews over five months in 2020 to gather market insights on how the top 20 Pharma are increasing productivity, efficiency, and speed of drug discovery in the short and long-term. These simple, stable compounds, used to treat various conditions, are the focus for 78% of preclinical research.
H1 Blog
JUNE 26, 2024
Worldwide Clinical Trials is a leading full-service global CRO (contract research organization) working with biotech and pharma to create customized solutions. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.
Drug Target Review
SEPTEMBER 5, 2024
However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.
Vial
MARCH 1, 2024
By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.
The Pharma Data
OCTOBER 14, 2020
The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models. The funds will be used to bring Ori’s innovative manufacturing platform to the market.
Expert insights. Personalized for you.
52 
Let's personalize your content